StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Amneal Pharmaceuticals's EV/EBITDA was 21.0× on Nov 11, 2026, against 17.8× a year earlier. Over the last 5 years it ranged from 12.3× to 68.1×, with a median of 19.8×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202621.0×+3.1
2025Dec 31, 202517.9×−6.8
2024Dec 31, 202424.7×+10.4
2023Dec 29, 202314.4×−9.0
2022Jul 29, 202223.4×+3.8
2021Dec 31, 202119.6×−47.7
2020Dec 31, 202067.3×−38.9
2019Jan 31, 2019106.2×−2.2
2018Dec 31, 2018108.4×–

More Amneal Pharmaceuticals figures

See a number that looks wrong?